MedPath

Melanocortin 4 Receptor Mutations and Obesity-associated Diseases

Completed
Conditions
Obesity
Interventions
Other: No intervention
Registration Number
NCT01849705
Lead Sponsor
University of Copenhagen
Brief Summary

Mutations in the melanocortin 4 receptor (MC4R) are the most common form of monogenic obesity, and can explain 2-6% of severe obesity.

Studies have shown that mutations in MC4R are associated with increased fat mass, height-for-age, appetite and insulin resistance among children. In adults, mutations in MC4R are less penetrant for these phenotypes but it has been observed that individuals with MC4R mutations have a smaller than expected blood pressure for their degree of obesity.

The purpose of this study is to explore the association between functional MC4R mutations and obesity, insulin resistance and blood pressure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
226
Inclusion Criteria
  • Age 18-70 years
  • Men and women
  • BMI > 30 kg/m^2
Exclusion Criteria
  • Uncontrolled type 2 diabetes
  • Bariatric surgery
  • Use of anti-obesity medication

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
All subjectsNo interventionNo intervention
Primary Outcome Measures
NameTimeMethod
Blood pressureBaseline

Systolic and diastolic blood pressure

Secondary Outcome Measures
NameTimeMethod
ObesityBaseline

Obesity measured as BMI

Blood glucoseBaseline

Blood glucose measured at baseline

MC4R mutationsBaseline

MC4R mutations detected by sequencing of the coding region of the MC4R gene

Trial Locations

Locations (1)

Department of Nutrition, Exercise and Sports, University of Copenhagen

🇩🇰

Frederiksberg, Frederiksberg C, Denmark

© Copyright 2025. All Rights Reserved by MedPath